Douglas S. Boothe was the leader of a little-known generic-drug maker seven years ago when federal agents approached his company with an urgent plea: Slash production of an addictive pain medication that was fueling a national crisis.
Democracy Dies in Darkness
Little-known makers of generic drugs played central role in opioid crisis, records show
July 27, 2019 at 12:25 p.m. EDT